Talk:Catalyst Pharmaceuticals

Recreated article
This article was previously deleted per an AfD discussion. I was the deleting administrator. I have determined that the current version of the article is sufficiently different that it is not eligible for G4 speedy deletion. --MelanieN (talk) 22:01, 8 September 2015 (UTC)

Unregistered accounts are trying to remove all negative criticism from this article
100.8.101.127, 2600:387:5:805::a4 and similar MAC address have repeatedly made non-constructive removal of material without any explanation. Looks to be blatantly bad faith removals to promote the company's image. Paid PR? — Preceding unsigned comment added by Shadybabs (talk • contribs) 01:12, 9 February 2019 (UTC)

Overinflated History of amifampridine Section? Related to bad faith criticism removal
Unregistered accounts made previous attempts, seemingly in bad faith, to remove the negative criticism. Since those attempts have been unsuccessful, it looks as though the added "History of amifampridine" section appears to be overinflated for the sake of filler, significantly moving down and dwarfing the criticism section. This added section appears to be filler because it is specifically a timeline of facts about that specific drug, as opposed to meaningful relevant information about the company. For example, "Amifampridine, also called 3,4-DAP, was discovered in Scotland in the 1970s, and doctors in Sweden first showed its use in LEMS in the 1980s." This is speculation that this is over-inflated filler in bad-faith, but it seems reasonable taking into account the previous attempts to remove the criticism section entirely. 12bfeldman (talk) 17:42, 9 August 2020 (UTC)